Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Rutkowski

Showing results (141-150 of 253) with videos related to

Pageof 26
Sort By:
Journal of Neuro-Oncology|January 22, 2024
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatmentDenise Obrecht-Sturm, Elke Pfaff, Martin Mynarek, et al.
Clinical Chemistry|August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal FluidAnn-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Neuro-Oncology Practice|May 14, 2026
Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-'87/'92 studiesHolger Ottensmeier, Matthias Eyrich, René Schmidt, et al.
Acta Neuropathologica Communications|November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2022
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trialChristian Hagel, Veronika Sloman, Martin Mynarek, et al.
Neuroradiology|February 17, 2025
Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-upAnnika Stock, Judith Krumma, Gudrun Fleischhack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91Stefan Rutkowski, André von Bueren, Katja von Hoff, et al.
Neuro-Oncology Practice|August 7, 2019
Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trialHugo Câmara-Costa, Kim S Bull, Colin Kennedy, et al.
Journal of Neuro-Oncology|October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studiesJonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.
Pageof 26

Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
Journal of Neuro-Oncology|January 22, 2024
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatmentDenise Obrecht-Sturm, Elke Pfaff, Martin Mynarek, et al.
Clinical Chemistry|August 25, 2023
Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal FluidAnn-Kristin Afflerbach, Christian Rohrandt, Björn Brändl, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Neuro-Oncology Practice|May 14, 2026
Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-'87/'92 studiesHolger Ottensmeier, Matthias Eyrich, René Schmidt, et al.
Acta Neuropathologica Communications|November 16, 2019
Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohortStephanie T Jünger, Martin Mynarek, Inken Wohlers, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2022
Refining M1 stage in medulloblastoma: criteria for cerebrospinal fluid cytology and implications for improved risk stratification from the HIT-2000 trialChristian Hagel, Veronika Sloman, Martin Mynarek, et al.
Neuroradiology|February 17, 2025
Recurrence patterns in pediatric intracranial ependymal neoplasm: a systematic imaging work-upAnnika Stock, Judith Krumma, Gudrun Fleischhack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91Stefan Rutkowski, André von Bueren, Katja von Hoff, et al.
Neuro-Oncology Practice|August 7, 2019
Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trialHugo Câmara-Costa, Kim S Bull, Colin Kennedy, et al.
Journal of Neuro-Oncology|October 17, 2021
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studiesJonas E Adolph, Gudrun Fleischhack, Christine Gaab, et al.
Pageof 26